DRE. Overall, 49 patients had a transurethral resection of the prostate (TURP). The cancerdetection rate on extended biopsy was correlated with risk factors using the chisquare test and multivariate analysis.
RESULTSExtended biopsy detected prostate cancer in 30 of the 83 men (36%), with positive cores in only 20 sextant biopsy sites (67%), in only seven in additional sites (23%), and both in three (10%). Of the 21 patients who had repeat extended biopsy, four (19%) had cancers. There were two carcinomas in the 49 TURP specimens (4%). The PSA level, DRE and transrectal ultrasonography findings were not predictive of cancer in extended biopsies (chisquare test). Patient age, PSA density and the number of cores with HGPIN (all P < 0.001) had a significant effect on the cancerdetection rate, and multivariate analysis showed that all three were independent predictors of cancer. A logistic regression model was designed to predict the probability of cancer in extended biopsy, with an overall accuracy of 78%.
CONCLUSIONExtended biopsy improved the cancer detection rate by 23% in patients with HGPIN. Patient age, PSA density and the number of cores with HGPIN were the only independent predictors of cancer.
KEYWORDSprostatic intraepithelial neoplasia, prostate cancer, extended needle biopsy